Quote:
Originally Posted by Ocala Mike
I'm in NVAX as a purely speculative play with some house money, hoping they develop an RSV vaccine and/or get bought out.
|
Fate has stepped in with this coronavirus thing, sending all vaccine company stocks higher. NVAX may be in line for some funding to develop a vaccine. Moreover, it should be announcing its results of the nanoflu vaccine trial any day now. RSV is on hold and needs funding for another trial.